In pediatric cancer, expression of MYCN is selectively confined to tumor tissue in medulloblastoma [8], neuroblastoma [1, 2], rhabdomyosarcoma [7], and a subset of retinoblastoma [9], four common solid tumors that together account for a substantial proportion of relapsed cancer deaths in children. The gene discussed is MYCN; the disease is neuroblastoma.